AVITA Medical, Inc. (RCEL) EBT Margin (2018 - 2026)

AVITA Medical (RCEL) has reported EBT Margin for 9 consecutive years, with 35.16% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT Margin rose 1868.0% year-over-year to 35.16%; the trailing twelve-month figure through Jun 2026 stood at 28.39% (up 4047.0% YoY), and the FY2025 full-year result was 67.83%, up 2834.0% from the prior year.
• EBT Margin eased to 35.16% in Q2 2026 per RCEL's latest filing, from 12.65% in the prior quarter.
• Across five years, EBT Margin topped out at 12.65% in Q4 2025 and bottomed at 167.76% in Q1 2024.
• Historically, EBT Margin has averaged 82.1% across 5 years, with a median of 80.13% in 2024.
• The sharpest annual moves came in 2024 and 2025: EBT Margin plunged 8065 bps in 2024, then jumped 9295 bps in 2025.
• Over 5 years, EBT Margin stood at 103.37% in 2022, then fell by 12 bps to 115.74% in 2023, then surged by 46 bps to 62.86% in 2024, then jumped by 80 bps to 12.65% in 2025, then plunged by 178 bps to 35.16% in 2026.
• According to Business Quant data, EBT Margin over the past three periods registered 35.16%, 12.65%, and 77.2% for Q2 2026, Q4 2025, and Q3 2025 respectively.